Researchers from the UNC School of Medicine and North Carolina State University showed that they could harvest and multiply lung stem cells in volumes sufficient for human therapy. In a second study, the team used their cell therapy to treat a model of idiopathic pulmonary fibrosis.
The scientists reported that they are in talks with the FDA to prepare for an initial clinical trial with IPF pat
Get the full story at our sister site, Drug Delivery Business News.